TRILUMINATE's primary endpoint was a hierarchical composite of death from any cause or tricuspid valve surgery, ...

Ben McCullough, 76, received an EVOQUE heart valve last fall. On Wednesday, he got to thank the makers face-to-face.

Ben McCullough met the 25 Edwards Lifesciences technicians who spent 20 hours hand-sewing 2,000 stitches to make a valve ...

Payment will be provided when TTVR is delivered for an FDA-approved indication in the context of a CMS-approved study.

CMS has approved Medicare and Medicaid coverage for transcatheter tricuspid valve replacement procedures for the treatment of ...

In a groundbreaking event for Arizona healthcare, HonorHealth Scottsdale Shea Medical Center recently became the first non-clinical trial site in the state to utilize the Edwards EVOQUE system for ...

Laplace Interventional announced today that it completed a Series C financing round to support its prosthetic heart valve technology.